Skip to content

Microneedling vs Dermabrasion for Early Facial Scar Resurfacing

Microneedling vs Dermabrasion for Early Facial Scar Resurfacing

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06171386
Enrollment
30
Registered
2023-12-14
Start date
2024-04-01
Completion date
2026-04-30
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar

Keywords

Dermabrasion, Microneedling, Surgical scars

Brief summary

This study aims to determine whether microneedling or dermabrasion in the early post-operative period is superior in improving the appearance of surgical scars on the face.

Detailed description

Microneedling and dermabrasion are two common modalities that may be performed in-office to treat surgical scars. Microneedling is a form of collagen induction therapy, often used in conjunction with platelet-rich plasma or hyaluronic acid. Dermabrasion is a technique that improves the skin structure, quality, and appearance of scars through collagen remodeling and reepithelization. To determine which modality is most effective, a prospective study; randomizing a volunteer sample of adult patients with new surgical vertical forehead scars will receive either dermabrasion or microneedling in the early postoperative period.

Interventions

PROCEDUREMicroneedling

a form of collagen induction therapy

PROCEDUREDermabrasion

a technique that improves the skin structure, quality, and appearance of scars through collagen remodeling and reepithelization

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients will be invited to participate in the study through the clinic setting - aim to have around 30 patient volunteers. Of the 30 patients, 15 will be randomized to receive microneedling, and 15 will receive dermabrasion.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Volunteer adult patients will be identified by visiting the Facial Plastics and Reconstructive Surgery Clinic at Atrium Health Wake Forest Baptist. * Patients will be 18 years old+ and have a vertical surgical scar in the superior 1/3 of the face (trichion to glabella). * Patients will enroll in the clinic research registry and indicate an interest in being involved in the study.

Exclusion criteria

* Patients who rate Types 4-6 on the Fitzpatrick scale will be excluded due to risk of poor outcome from dermabrasion. * There are no other planned

Design outcomes

Primary

MeasureTime frameDescription
Change in Vancouver Scar Scale ScoresMonth 7Four characteristics of the scar are assessed. These are: vascularity, height, pliability, and pigmentation. Each characteristic is given a score, which are added together to give an overall score between 0 and 13 - lower scores denoting normal skin
Change in Patient and Observer Scar Assessment Scale ScoresMonth 7Items and total scale scores for the patient and observer: Each item on both scales has a score of 1 to 10. The lowest score is 1 and corresponds to the normal skin situation. The total score of both scales can be calculated simply by adding the scores of each of the six items. The total score will range from 6 to 60 - lower scores denoting normal skin
Change in Global Aesthetic Improvement Scale ScoresMonth 75-point scale wherein 2 = much improved (marked improvement in appearance), 1 = improved (improvement in appearance but a touch-up or re-treatment is indicated - lower scores denoting normal skin

Secondary

MeasureTime frameDescription
Patient perceived benefitAt time of procedure (pain scale); at 6 months (yes/no)At the time of intervention, patients will be asked to rank pain of procedure on a scale of 1-10 (1: minimal discomfort, 10: severe pain). At 6 months, they will also give a yes/no response as to whether they would undergo the study protocol (procedure) again.

Countries

United States

Contacts

Primary ContactCandace M Waters, MD
cmwaters@wakehealth.edu336-716-4000
Backup ContactLauren G Himes, MD
lhimes@wakehealth.edu336-716-3850

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026